Lenk; Robert P.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lenk; Robert P..The latest application filed is for "biomarker-targeting contrast agents and their use in magnetic resonance imaging for detection of atherosclerotic plaque".
- Lenk; Robert P. - Danville VA
- Lenk, Robert P. - US
- Lenk; Robert P. - Lambertville NJ
- Lenk; Robert P. - New Waverly TX
- Lenk; Robert P. - Willis TX
- Lenk; Robert P. - The Woodlands TX
| Patent | Date |
|---|---|
| Metallofullerene contrast agents Grant 9,233,177 - Macfarland , et al. January 12, 2 | 2016-01-12 |
| Biomarker-targeting Contrast Agents And Their Use In Magnetic Resonance Imaging For Detection Of Atherosclerotic Plaque App 20140161733 - Zhou; Zhiguo ; et al. | 2014-06-12 |
| Fullerene therapies for inflammation Grant 8,680,125 - Kepley , et al. March 25, 2 | 2014-03-25 |
| Amphiphilic or lipophilic polar functionalized fullerenes and their uses Grant 8,241,648 - Zhou , et al. August 14, 2 | 2012-08-14 |
| Fullerene Therapies For Inflammation And Inhibition Of Build-up Of Arterial Plaque App 20110251158 - KEPLEY; Christopher L. ; et al. | 2011-10-13 |
| Method For Inhibiting The Build-up Of Arterial Plaque By Administering Fullerenes App 20110190251 - Kepley; Christopher L. ; et al. | 2011-08-04 |
| Metallofullerene Contrast Agents App 20110124848 - Macfarland; Darren K. ; et al. | 2011-05-26 |
| Fullerene Therapies For Inflammation App 20110028522 - Kepley; Christopher L. ; et al. | 2011-02-03 |
| Method For Treating Wounds By Administering Fullerenes App 20110021630 - Kepley; Christopher L. ; et al. | 2011-01-27 |
| Method For Treating Pruritus By Administering Fullerenes App 20110009486 - Kepley; Christopher ; et al. | 2011-01-13 |
| Using Fullerenes To Enhance And Stimulate Hair Growth App 20110003773 - Kepley; Christopher L. ; et al. | 2011-01-06 |
| Amphiphilic or lipophilic polar functionalized fullerenes and their uses App 20080213324 - Zhou; Zhiguo ; et al. | 2008-09-04 |
| Liposome carriers for in vivo delivery of fullerenes App 20080213352 - Lenk; Robert P. ; et al. | 2008-09-04 |
| Steroid derivatives of fullerenes App 20080214514 - MacFarland; Darren ; et al. | 2008-09-04 |
| Low toxicity drug-lipid systems App 20020119170 - Janoff, Andrew S. ; et al. | 2002-08-29 |
| Method for size separation of particles Grant 5,948,441 - Lenk , et al. September 7, 1 | 1999-09-07 |
| Liposomal-polyene preliposomal powder and method for its preparation Grant 5,830,498 - Lenk , et al. November 3, 1 | 1998-11-03 |
| Formulation and use of carotenoids in treatment of cancer Grant 5,811,119 - Mehta , et al. September 22, 1 | 1998-09-22 |
| Low toxicity drug-lipid systems Grant 5,616,334 - Janoff , et al. April 1, 1 | 1997-04-01 |
| Localized delivery using fibronectin conjugates Grant 5,366,958 - Weiner , et al. November 22, 1 | 1994-11-22 |
| Prostaglandin-lipid formulations Grant 5,262,168 - Lenk , et al. November 16, 1 | 1993-11-16 |
| Liposomal-polyene preliposomal powder and method for its preparation Grant 5,178,875 - Lenk , et al. January 12, 1 | 1993-01-12 |
| Stable plurilamellar vesicles Grant 5,169,637 - Lenk , et al. * December 8, 1 | 1992-12-08 |
| Prostaglandin-lipid formulations Grant 5,082,664 - Lenk , et al. January 21, 1 | 1992-01-21 |
| Drug preparations of reduced toxicity Grant 5,059,591 - Janoff , et al. October 22, 1 | 1991-10-22 |
| Stable plurilamellar vesicles Grant 5,030,453 - Lenk , et al. * July 9, 1 | 1991-07-09 |
| Enhancement of pharmaceutical activity Grant 5,000,958 - Fountain , et al. March 19, 1 | 1991-03-19 |
| Therapeutic treatment by intramammary infusion Grant 4,981,692 - Popescu , et al. January 1, 1 | 1991-01-01 |
| Drug preparations of reduced toxicity Grant 4,897,384 - Janoff , et al. January 30, 1 | 1990-01-30 |
| Stable plurilamellar vesicles, their preparation and use Grant 4,522,803 - Lenk , et al. June 11, 1 | 1985-06-11 |
| SEC | 0001362635 | Lenk Robert P |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 